Literature DB >> 3797155

Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland.

.   

Abstract

Although the prevalence of clinical hypertension is of a far lesser magnitude in children than adults, there is ample evidence to support the concept that the roots of essential hypertension extend back into childhood. Prospective cohort data that could yield precise information about the relationship between childhood BP and cardiovascular risk are not yet available. Nonetheless, high BP in children represents a significant clinical problem which in 1977 was comprehensively addressed by the Task Force on Blood Pressure Control in Children. Contained herein, 10 years later, is the revised version of the original Task Force report including normative BP data derived from sampling more than 70,000 children, as well as advice on methodology and instrumentation for BP measurement, guidelines for detecting children with high BP, and strategies for appropriate diagnostic evaluation and pharmacologic and nonpharmacologic treatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3797155

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  219 in total

Review 1.  Diagnosis of high blood pressure in children by means of ambulatory blood pressure monitoring.

Authors:  E Lurbe; J Redon
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

2.  Secular trends in BMI and blood pressure among children and adolescents: the Bogalusa Heart Study.

Authors:  David S Freedman; Alyson Goodman; Omar A Contreras; Pronabesh DasMahapatra; Sathanur R Srinivasan; Gerald S Berenson
Journal:  Pediatrics       Date:  2012-06-04       Impact factor: 7.124

Review 3.  Are pitfalls of oxcillometric blood pressure measurements preventable in children?

Authors:  Lavjay Butani; Bruce Z Morgenstern
Journal:  Pediatr Nephrol       Date:  2003-04       Impact factor: 3.714

4.  Renal biopsy for 24-h urine protein excretion of 1.5 g/day.

Authors:  T M Barratt
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

Review 5.  Strengths and limitations of current pediatric blood pressure nomograms: a global overview with a special emphasis on regional differences in neonates and infants.

Authors:  Massimiliano Cantinotti; Raffaele Giordano; Marco Scalese; Sabrina Molinaro; Bruno Murzi; Nadia Assanta; Maura Crocetti; Marco Marotta; Sergio Ghione; Giorgio Iervasi
Journal:  Hypertens Res       Date:  2015-04-16       Impact factor: 3.872

6.  Blood pressure nomograms for school children in Iran.

Authors:  Neamatollah Ataei; Asghar Aghamohammadi; Effat Yousefi; Mostafa Hosseini; Keramat Nourijelyani; Mehdy Tayebi; Gholamhasan Khorasani; Arash Chavoshian; Mohsen Hosseini; Mohammad Yousefi
Journal:  Pediatr Nephrol       Date:  2003-12-18       Impact factor: 3.714

7.  Maternal protein intake is not associated with infant blood pressure.

Authors:  Susanna Y Huh; Sheryl L Rifas-Shiman; Ken P Kleinman; Janet W Rich-Edwards; Steven E Lipshultz; Matthew W Gillman
Journal:  Int J Epidemiol       Date:  2004-12-02       Impact factor: 7.196

Review 8.  Cardiovascular disease risk factors and atherosclerosis in children and adolescents.

Authors:  S R Daniels
Journal:  Curr Atheroscler Rep       Date:  2001-11       Impact factor: 5.113

9.  Risk factors for persistent proteinuria after a 2-year combination therapy for severe childhood IgA nephropathy.

Authors:  Koichi Kamei; Koichi Nakanishi; Shuichi Ito; Kenji Ishikura; Hiroshi Hataya; Masataka Honda; Kandai Nozu; Kazumoto Iijima; Yuko Shima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2014-12-10       Impact factor: 3.714

10.  Increased blood pressure in adolescents of low socioeconomic status with short stature.

Authors:  Maria Teresa Bechere Fernandes; Ricardo Sesso; Paula Andrea Martins; Ana Lydia Sawaya
Journal:  Pediatr Nephrol       Date:  2003-04-03       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.